EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 43 / No 1 (March 2011) J Extra Corpor Technol, 43 1 (2011) P52-P57 References
Free Access
Issue
J Extra Corpor Technol
Volume 43, Number 1, March 2011
Page(s) P52 - P57
DOI https://doi.org/10.1051/ject/201143P52
Published online 15 March 2011
  1. Carville DG, Schleckser PA, Guyer KE, Corsello M, Walsh MM. Whole blood platelet function assay on the ICHOR point-of-care hematology analyzer. J Extra Corpor Technol. 1998;30:171–7. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Enriquez LJ, Shore-Lesserson L. Point-of-care coagulation testing and transfusion algorithms. Br J Anaesth. 2009;103(Suppl 1):i14–22. Review. [CrossRef] [Google Scholar]
  3. Bull BS, Korpman RA, Huse WM, Briggs BD. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols. J Thorac Cardiovas Surg. 1975;69:674–84. [CrossRef] [Google Scholar]
  4. Garvin S, Fitzgerald DC, Despotis G, Shekar P, Body SC. Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements. Anesth Analg. 2010;111:849–55. [CrossRef] [PubMed] [Google Scholar]
  5. Slight RD, Buell R, Nzewi OC, McClelland DB, Mankad PS. A comparison of activated coagulation time-based techniques for anti-coagulation during cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2008;22:47–52. [CrossRef] [Google Scholar]
  6. Mirow N, Zittermann A, Koertke H, et al. Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery. J Cardiovasc Surg (Torino). 2008;49:277–84. [PubMed] [Google Scholar]
  7. Sellevold OF, Berg TM, Rein KA, Levang OW, Iversen OJ, Bergh K. Heparin-coated circuit during cardiopulmonary bypass. A clinical study using closed circuit, centrifugal pump and reduced heparinization. Acta Anaesthesiol Scand. 1994;38:372–9. [CrossRef] [PubMed] [Google Scholar]
  8. Sáenz A, Larrañaga G, Alvarez L, et al. Heparin-coated circuit in coronary surgery. A clinical study. Eur J Cardiothorac Surg. 1996;10:48–53. [CrossRef] [Google Scholar]
  9. Kolff WJ, Effler DB, Groves LK, Peereboom G, Moraca PP. Disposable membrane oxygenator (heart-lung machine) and its use in experimental surgery. Cleve Clin Q. 1956;23:69–97. [CrossRef] [Google Scholar]
  10. Teoh KH, Young E, Blackall MH, Roberts RS, Hirsh J. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery? J Thorac Cardiovasc Surg. 2004;128:211–9. [CrossRef] [Google Scholar]
  11. Martin P, Horkay F, Gupta NK, Gebitekin C, Walker DR. Heparin rebound phenomenon–much ado about nothing? Blood Coagul Fibrinolysis. 1992;3:187–91. [PubMed] [Google Scholar]
  12. Shore-Lesserson L, Reich DL, DePerio M. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients. Can J Anaesth. 1998;45:10–8. [CrossRef] [PubMed] [Google Scholar]
  13. Griffin MJ, Rinder HM, Smith BR, et al. The effects of heparin, protamine, and heparin/protamine reversal on platelet function under conditions of arterial shear stress. Anesth Analg. 2001;93:20–7. [CrossRef] [PubMed] [Google Scholar]
  14. Levy JH, Tanaka KA. Anticoagulation and reversal paradigms: Is too much of a good thing bad? Anesth Analg. 2009;108:692–4. [CrossRef] [PubMed] [Google Scholar]
  15. Koster A, Böttcher W, Merkel F, Hetzer R, Kuppe H. The more closed the bypass system the better: A pilot study on the effects of reduction of cardiotomy suction and passive venting on hemostatic activation during on-pump coronary artery bypass grafting. Perfusion. 2005;20:285–8. [CrossRef] [PubMed] [Google Scholar]
  16. Casalino S, Stelian E, Novelli E, et al. Reduced transfusion requirements with a closed cardiopulmonary bypass system. J Cardiovasc Surg (Torino). 2008;49:363–9. [PubMed] [Google Scholar]
  17. Hussaini BE, Treanor PR, Healey NA, Lu XG, Khuri SF, Thatte HS. Multifactorial comparison of modified and conventional perfusion strategies in a porcine model of cardiopulmonary bypass. J Surg Res. [Epub 2010 Feb 16]. [Google Scholar]
  18. Lindholm L, Westerberg M, Bengtsson A, Ekroth R, Jensen E, Jeppsson A. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients. Ann Thorac Surg. 2004;78:2131–8. [CrossRef] [Google Scholar]
  19. Joviæ MD, Calija BM, Radomir BJ, et al. The use of acute normovolemic hemodilution in patients undergoing cardiac surgery. Cardiovasc Surg. 2003;11:201–5. [CrossRef] [PubMed] [Google Scholar]
  20. Zisman E, Eden A, Shenderey A, et al. The effect of acute autologous blood transfusion on coagulation dysfunction after cardiopulmonary bypass. Eur J Anaesthesiol. 2009;26:868–73. [CrossRef] [PubMed] [Google Scholar]
  21. Balachandran S, Cross MH, Karthikeyan S, Mulpur A, Hansbro SD, Hobson P. Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion after coronary artery surgery. Ann Thorac Surg. 2002;73:1912–8. [CrossRef] [Google Scholar]
  22. Saczkowski R, Bernier PL, Tchervenkov CI, Arellano R. Retrograde autologous priming and allogeneic blood transfusions: A meta-analysis. Interact Cardiovasc Thorac Surg. 2009;8:373–6. Review [Epub 2008 Dec 15]. [CrossRef] [PubMed] [Google Scholar]
  23. Raman JS, Hata M, Bellomo R, Kohchi K, Cheung HL, Buxton BF. Hemofiltration during cardiopulmonary bypass for high risk adult cardiac surgery. Int J Artif Organs. 2003;26:753–7. [CrossRef] [PubMed] [Google Scholar]
  24. Boodhwani M, Hamilton A, de Varennes B, et al. A multicenter randomized controlled trial to assess the feasibility of testing modified ultrafiltration as a blood conservation technology in cardiac surgery. J Thorac Cardiovasc Surg. 2010;139:701–6. [CrossRef] [Google Scholar]
  25. Roeder B, Graham S, Searles B, Darling E. Evaluation of the hemobag: A novel ultrafiltration system for circuit salvage. J Extra Corpor Technol. 2004;36:162–5. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  26. Beckmann SR, Carlile D, Bissinger RC, Burrell M, Winkler T, Shely WW. Improved coagulation and blood conservation in the golden hours after cardiopulmonary bypass. J Extra Corpor Technol. 2007;39:103–8. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  27. von Heymann C, Sander M, Foer A, et al. The impact of an hematocrit of 20% during normothermic cardiopulmonary bypass for elective low risk coronary artery bypass graft surgery on oxygen delivery and clinical outcome–a randomized controlled study. Crit Care. 2006;10:R58. [CrossRef] [PubMed] [Google Scholar]
  28. Karkouti K, Beattie WS, Wijeysundera DN. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg. 2005;129:391–400. [CrossRef] [Google Scholar]
  29. Karkouti K, Djaiani G, Borger MA, et al. Low hematocrit during cardiopulmonary bypass is associated with increased risk of peri operative stroke in cardiac surgery. Ann Thorac Surg. 2005;80:1381–7. [CrossRef] [Google Scholar]
  30. Surgenor SD, DeFoe GR, Fillinger MP, et al. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation. 2006;114(Suppl):I43–8. [CrossRef] [PubMed] [Google Scholar]
  31. Mathew JP, Mackensen GB, Phillips-Bute B, et al. Effects of extreme hemodilution during cardiac surgery on cognitive function in the elderly. Neurologic Outcome Research Group (NORG) of the Duke Heart Center. Anesthesiology. 2007;107:577–84. [CrossRef] [PubMed] [Google Scholar]
  32. Shaz BH, Dente CJ, Nicholas J, et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion. 2010;50:493–500. [CrossRef] [PubMed] [Google Scholar]
  33. Murad MH, Stubbs JR, Gandhi MJ, Wang AT, Paul A, Erwin PJ, et al. The effect of plasma transfusion on morbidity and mortality: A systematic review and meta-analysis. Transfusion. [Epub 2010 Mar 19]. [PubMed] [Google Scholar]
  34. Karlsson M, Ternström L, Hyllner M, et al. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost. 2009;102:137–44. [Google Scholar]
  35. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: An in vitro model. Br J Anaesth. 2009;102:793–9. [Epub 2009 May 6]. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.